Rondol Group

We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These features allow for a more effective delivery of Active Pharmaceutical Ingredients, which means more efficient therapies with potentially fewer side effects. The precision and control that the All-in One machine provides during the extrusion process can also help to reduce drug development costs, an economic benefit that could have broad implications for the pharmaceutical industry. In 2017 we installed our application lab in Nancy where we are neighbors to our partner Institut Jean Lamour, a prestigious research lab at the forefront of Materials Science, Electronics and Healthcare. In 2018 we raised funds in the USA and in 2020 we were nominated together with BASF at the Galien Awards in New York. In 2021 we signed a global technology partnership with the French Pharma group SEQENS and a research agreement against child malaria with BASF and Queens University Belfast. In 2022, we presented our research at Pharma Sci 360° Boston, both on Antimalarials with BASF and Queens University Belfast, and on Aspirin with SEQENS and Institut Jean Lamour. This was a great success! In May 2023, we opened our new offices in Canada at Concordia University to cover the North American market, and we were nominated for the best Start Up Award by the Galien Foundation.